We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$75.6B
AUM Growth
+$332M
(+0.44%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
9.2%
Holding
2,306
New
139
Increased
928
Reduced
1,013
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$234M |
| 2 |
eBay
EBAY
|
+$223M |
| 3 |
Walt Disney
DIS
|
+$189M |
| 4 |
Humana
HUM
|
+$184M |
| 5 |
DXC Technology
DXC
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$236M |
| 2 |
Citizens Financial Group
CFG
|
+$157M |
| 3 |
Applied Materials
AMAT
|
+$156M |
| 4 |
Huntsman Corp
HUN
|
+$154M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.77% |
| 2 | Technology | 16.07% |
| 3 | Industrials | 14.94% |
| 4 | Consumer Discretionary | 12.29% |
| 5 | Healthcare | 11.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Medtronic
MDT
$110B
| $65M | 0.09% |
732,174
+163,102
| +29% | +$13.8M |
|
302
Halliburton
HAL
$27B
| $64.9M | 0.09% |
1,519,596
+386,424
| +34% | +$17.7M |
|
303
AbbVie
ABBV
$432B
| $64.9M | 0.09% |
894,791
-46,033
| -5% | -$3.09M |
|
|
Y
304
DELISTED
Alleghany Corp
Y
| $64.5M | 0.09% |
108,472
+5,065
| +5% | +$3.01M |
|
305
MSCI
MSCI
$41.7B
| $64.3M | 0.09% |
624,184
-111,968
| -15% | -$11.3M |
|
306
Dr. Reddy's Laboratories
RDY
$10.1B
| $63.9M | 0.08% |
7,585,790
-2,463,540
| -25% | -$20M |
|
307
Globe Life
GL
$14.3B
| $63.8M | 0.08% |
833,407
+2,308
| +0.3% | +$176K |
|
|
BBBY
308
DELISTED
Bed Bath & Beyond Inc
BBBY
| $63.5M | 0.08% |
2,089,573
+1,745,562
| +507% | +$63.1M |
|
309
RenaissanceRe
RNR
$13.4B
| $62.9M | 0.08% |
452,022
+67,595
| +18% | +$9.5M |
|
310
Teleflex
TFX
$6.22B
| $62.7M | 0.08% |
301,644
-69,282
| -19% | -$13.9M |
|
311
Yum! Brands
YUM
$40.3B
| $62.6M | 0.08% |
848,563
-132,525
| -14% | -$9.22M |
|
312
S&P Global
SPGI
$122B
| $62.4M | 0.08% |
427,338
-149,315
| -26% | -$20.7M |
|
313
Freeport-McMoran
FCX
$96.6B
| $61.8M | 0.08% |
5,144,177
+4,409,036
| +600% | +$53.5M |
|
314
Teck Resources
TECK
$31.9B
| $61.6M | 0.08% |
3,560,945
-1,302,649
| -27% | -$24.9M |
|
315
Macy's
M
$6.92B
| $61.2M | 0.08% |
2,631,876
+1,999,199
| +316% | +$51.2M |
|
316
Avnet
AVT
$7.63B
| $60.8M | 0.08% |
1,563,115
-248,486
| -14% | -$9.84M |
|
|
PF
317
DELISTED
Pinnacle Foods, Inc.
PF
| $60.2M | 0.08% |
1,012,680
+508,859
| +101% | +$30.4M |
|
318
RTX Corp
RTX
$294B
| $60.1M | 0.08% |
782,222
-894,739
| -53% | -$67M |
|
319
Fair Isaac
FICO
$22.6B
| $59.9M | 0.08% |
429,638
+6,716
| +2% | +$898K |
|
320
CME Group
CME
$94.6B
| $59.8M | 0.08% |
477,855
-803
| -0.2% | -$96K |
|
321
Leidos
LDOS
$16.6B
| $59.3M | 0.08% |
1,147,913
-324,117
| -22% | -$17.3M |
|
322
BWX Technologies
BWXT
$16.2B
| $59.3M | 0.08% |
1,216,464
-529,320
| -30% | -$25.6M |
|
323
Liberty Global Class C
LBTYK
$3.6B
| $59.1M | 0.08% |
1,895,443
+1,701,441
| +877% | +$53.1M |
|
324
Dana Inc
DAN
$2.98B
| $59M | 0.08% |
2,643,480
-440,262
| -14% | -$8.94M |
|
325
Regal Rexnord
RRX
$14.7B
| $59M | 0.08% |
723,651
+66,088
| +10% | +$5.22M |
|
Similar funds
AQR Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, AQR Capital Management held 2,306 positions worth $75.6B, up 0.44% from $75.2B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
AQR Capital Management's Q2 2017 filing shows 139 new, 928 increased, 1,013 reduced and 118 closed positions. Its largest new stake was DXC Technology: 2,594,054 shares worth $172M. The largest sale was Wells Fargo, an estimated $236M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
- AQR Capital Management's largest Q2 2017 buy was DXC Technology: 2,594,054 shares worth $172M.
- AQR Capital Management added most to Gilead Sciences in Q2 2017, an estimated $234M increase.
- AQR Capital Management's biggest Q2 2017 reduction was Wells Fargo, cutting an estimated $236M.
- AQR Capital Management fully exited Computer Sciences in Q2 2017, selling an estimated $77.8M.
- AQR Capital Management's ten largest holdings make up 9.2% of its $75.6B portfolio in Q2 2017.
- AQR Capital Management opened 139 new positions and closed 118 in Q2 2017.
- AQR Capital Management's portfolio value rose 0.44% quarter-over-quarter to $75.6B.
Based on AQR Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.